Hemofiltration methods for treatment of diseases in a mammal

Details Hemofiltration methods for treatment of diseases in a mammal Hemofiltration methods for treatment of diseases in a mammal

2007-11-06

2007-11-06

Kim, John (Department: 1723)

Surgery

Blood drawn and replaced or treated and returned to body

Constituent removed from blood and remainder returned to body

C210S650000, C210S651000, C210S660000, C604S004010, C604S005010, C604S005040, C604S006110

Reexamination Certificate

active

10843933

ABSTRACT:
A hemofiltration system and method to treat an Inflammatory Mediator Related Disease in a mammal, including chronic and acute diseases, include a hemofilter and an adsorptive device. The hemofilter removes ultrafiltrate from a blood stream extracted from the mammal to create a filtered blood stream and an ultrafiltrate stream. The adsorptive device may include one or more adsorbent materials and may be used to adsorb inflammatory mediators from the ultrafiltrate stream received from the hemofilter to create a post adsorption ultrafiltrate stream. The post adsorption ultrafiltrate stream may be selectively combined with the filtered blood stream and together with the filtered blood stream may be returned to the mammal.

REFERENCES:
patent: 2682268 (1954-06-01), Ryan et al.
patent: 4000072 (1976-12-01), Sato et al.
patent: 4172071 (1979-10-01), De Maeyer et al.
patent: 4180460 (1979-12-01), Calari
patent: 4248736 (1981-02-01), Fuchigami et al.
patent: 4313831 (1982-02-01), Lehmann et al.
patent: 4355906 (1982-10-01), Ono
patent: 4362155 (1982-12-01), Skurkovich
patent: 4402940 (1983-09-01), Nose et al.
patent: 4581141 (1986-04-01), Ash
patent: 4596779 (1986-06-01), Ono
patent: 4614513 (1986-09-01), Bensinger
patent: 4618343 (1986-10-01), Polaschegg
patent: 4708799 (1987-11-01), Gerlach et al.
patent: 4781068 (1988-11-01), Pradelli
patent: 4784974 (1988-11-01), Butt
patent: 4844810 (1989-07-01), Richalley et al.
patent: 4863609 (1989-09-01), Schnabel et al.
patent: 4872983 (1989-10-01), Dimantoglou et al.
patent: 4874522 (1989-10-01), Okamoto et al.
patent: 4897189 (1990-01-01), Greenwood et al.
patent: 4900720 (1990-02-01), Kotitschke
patent: 4968432 (1990-11-01), Antwiler
patent: 5044901 (1991-09-01), Fumero et al.
patent: 5211850 (1993-05-01), Shettigar et al.
patent: 5286449 (1994-02-01), Kuroda et al.
patent: 5450516 (1995-09-01), Pasquali et al.
patent: 5523096 (1996-06-01), Okarma et al.
patent: 5536412 (1996-07-01), Ash
patent: 5571418 (1996-11-01), Lee et al.
patent: 5578223 (1996-11-01), Bene et al.
patent: 5661124 (1997-08-01), Hoffman et al.
patent: 5683584 (1997-11-01), Wenthold et al.
patent: 5744042 (1998-04-01), Stange et al.
patent: 5762798 (1998-06-01), Wenthold et al.
patent: 5808181 (1998-09-01), Wamsiedler et al.
patent: 5846419 (1998-12-01), Nederlof
patent: 5851394 (1998-12-01), Shibata et al.
patent: 5855782 (1999-01-01), Falkenhagen et al.
patent: 5858238 (1999-01-01), McRea et al.
patent: 5905141 (1999-05-01), Rausch et al.
patent: 5919369 (1999-07-01), Ash
patent: 5919444 (1999-07-01), Norman, Jr.
patent: 5931802 (1999-08-01), Yoshida et al.
patent: 5944684 (1999-08-01), Roberts et al.
patent: 5945337 (1999-08-01), Brown
patent: 5986062 (1999-11-01), Ohmura et al.
patent: 6008199 (1999-12-01), Grinnell et al.
patent: 6022477 (2000-02-01), Luo et al.
patent: 6039946 (2000-03-01), Strahilevitz
patent: 6042784 (2000-03-01), Wamsiedler et al.
patent: 6156734 (2000-12-01), Grinnell et al.
patent: 6191114 (2001-02-01), Vallespi et al.
patent: 6193681 (2001-02-01), Davidner et al.
patent: 6280632 (2001-08-01), Polaschegg
patent: 6287516 (2001-09-01), Matson et al.
patent: 6497675 (2002-12-01), Davankov
patent: 6595943 (2003-07-01), Burbank
patent: 6667299 (2003-12-01), Ahlem et al.
patent: 6730266 (2004-05-01), Matson et al.
patent: 6736972 (2004-05-01), Matson
patent: 6905688 (2005-06-01), Rosen et al.
patent: 2004/0199099 (2004-10-01), Matson et al.
patent: 2004/0228829 (2004-11-01), Roberts et al.
patent: 2006/0129082 (2006-06-01), Rozga
patent: 0 098 392 (1983-06-01), None
patent: 0 787 500 (1997-08-01), None
patent: 2124511 (1984-02-01), None
patent: 95/04559 (1995-02-01), None
Seiichi Mochizuki et al.'s “Extran transport through asymmetric ultrafilitration membranes: Comparison with hydrodynamic models”. Jouranl of Membrane Science, 68 (1992) pp. 21-41, 1992.
International Search Report PCT/US02/23603 5 pages, mailed Apr. 15, 2003.
International Search Report PCT/US03/07784 6 pages, mailed Jul. 17, 2003.
Konstantin et al. “Artificial Liver” from Artificial Organs vol. 16 Issue pp. 235-242 Blackwell Publications Inc. Boston MA 1992 International Society for Artificial Organs, 1992.
“Hemodiafiltration in Two Chambers Without Replacement Fluid: A Clinical Study” by C. Sanz-Moreno and J. Botella, Artificial Organs vol. 19 No. 5 1995.
International Search Report for PCT/US/99/15426.
Bende et al., “Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine enotoxin shock”. Circ Shock, vol. 19(2), pp. 239-244, 1986.
Nagaki et al., “Removal of endotoxin and cytokines by absorbents and the effect of plasma protein binding”. Int Journal of Artificial Organs, vol. 14(1), pp. 43-50, Jan. 1991.
Nagaki et al., “In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines”. Circ Shock, vol. 38(3), pp. 182-188, Nov. 1992.
Huges et al., “Use of sorbent columns and haemofiltration in fulminant hepatic failure”. Blood Purif. vol. 11(3), pp. 163-169, 1993.
Nagaki et al., “Clearance and tissue distribution of staphylococcal enterotoxin A in the rat and potential use of adsorbents for removal from plasma”, Journal of Med. Microbiology, vol. 38(5), pp. 354-359, May 1993.
Tetta et al., “Continuous plasma filtration coupled with sorbents”. Kidney Int. Suppl., vol. 53, pp. S186-S189, May 1998.
Pusey et al., “Experimental models of plasma perfusion”. Journal of Clin. Apheresis, vol. 6(2), pp. 99-102, 1991.
Geiger et al., “Biochemical assessment and clinical evaluation of bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice”. Int. Journal of Artificial Organs, vol. 15(1), pp. 35-39, Jan. 1992.
Tetta et al., “Removal of cytokines and activated complement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption”. Nephrol Dial. Transplant, vol. 13(6), pp. 1458-1464, Jun. 1998.
Rinaldo Bellomo et al., Nomenclature for Continuous Renal Replacement Therapy Atlas of Hemofiltration, p. 11-14.
“A Dangerous Error in the Dilution of 25 Percent Albumin”, The New England Journal of Medicine, vol. 338:1226-1227, No. 17, http://content.nejrn.org/cgi/content/extract/338/17/1226, 2 pgs.
ZLB Behring, Albumin (Human) USP, 25%, Albuminar -25, RX Only, 7 pgs.

Affiliated with

Also associated with

Rating

Hemofiltration methods for treatment of diseases in a mammal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hemofiltration methods for treatment of diseases in a mammal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemofiltration methods for treatment of diseases in a mammal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3824036